PortfoliosLab logoPortfoliosLab logo
CNCR vs. URNM
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

CNCR vs. URNM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and NorthShore Global Uranium Mining ETF (URNM). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CNCR vs. URNM - Yearly Performance Comparison


Returns By Period


CNCR

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*

URNM

1D
-0.72%
1M
-8.59%
YTD
15.52%
6M
7.45%
1Y
101.04%
3Y*
30.67%
5Y*
20.32%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CNCR vs. URNM - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than URNM's 0.85% expense ratio.


Return for Risk

CNCR vs. URNM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

URNM
URNM Risk / Return Rank: 8484
Overall Rank
URNM Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
URNM Sortino Ratio Rank: 8888
Sortino Ratio Rank
URNM Omega Ratio Rank: 7878
Omega Ratio Rank
URNM Calmar Ratio Rank: 8989
Calmar Ratio Rank
URNM Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. URNM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and NorthShore Global Uranium Mining ETF (URNM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CNCR vs. URNM - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


CNCRURNMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.71

Dividends

CNCR vs. URNM - Dividend Comparison

CNCR has not paid dividends to shareholders, while URNM's dividend yield for the trailing twelve months is around 2.75%.


TTM202520242023202220212020
CNCR
Loncar Cancer Immunotherapy ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
URNM
NorthShore Global Uranium Mining ETF
2.75%3.18%3.18%3.63%0.00%6.70%2.57%

Drawdowns

CNCR vs. URNM - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum URNM drawdown of -50.78%. Use the drawdown chart below to compare losses from any high point for CNCR and URNM.


Loading graphics...

Drawdown Indicators


CNCRURNMDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-50.78%

+50.78%

Max Drawdown (1Y)

Largest decline over 1 year

-30.79%

Max Drawdown (5Y)

Largest decline over 5 years

-50.78%

Current Drawdown

Current decline from peak

0.00%

-24.50%

+24.50%

Average Drawdown

Average peak-to-trough decline

0.00%

-17.89%

+17.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.29%

Volatility

CNCR vs. URNM - Volatility Comparison


Loading graphics...

Volatility by Period


CNCRURNMDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.93%

Volatility (6M)

Calculated over the trailing 6-month period

40.47%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

51.56%

-51.56%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

47.93%

-47.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

46.73%

-46.73%